The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
106066262 10606626 2 F 20140729 20160721 20141125 20160804 EXP JP-MALLINCKRODT-T201404157 MALLINCKRODT 74.00 YR M Y 45.00000 KG 20160804 CN JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
106066262 10606626 1 PS METHADONE METHADONE HYDROCHLORIDE 1 Oral 10 MG (30 MG DAILY DOSE) Y UNKNOWN 40517 TABLET
106066262 10606626 2 SS METHADONE METHADONE HYDROCHLORIDE 1 Oral 10 MG (20 MG DAILY DOSE) Y UNKNOWN 40517 TABLET
106066262 10606626 3 SS FENTOS FENTANYL 1 Transdermal 8 MG (8 MG DAILY DOSE) U U UNKNOWN 0
106066262 10606626 4 SS FENTOS FENTANYL 1 Transdermal 2 MG (2 MG DAILY DOSE) U U UNKNOWN 0
106066262 10606626 5 SS FENTOS FENTANYL 1 Transdermal 2 MG (2 MG DAILY DOSE) U U UNKNOWN 0
106066262 10606626 6 SS LYRICA PREGABALIN 1 Oral 75 MG (75 MG DAILY DOSE) U U UNKNOWN 0
106066262 10606626 7 C ABSTRAL FENTANYL CITRATE 1 Sublingual 200 ?G, 100 ?G U 0 SUBLINGUAL TABLET
106066262 10606626 8 C XTANDI ENZALUTAMIDE 1 Oral 160 MG U 0
106066262 10606626 9 C MUCOSTA REBAMIPIDE 1 Oral 200 MG U 0
106066262 10606626 10 C LOXONIN LOXOPROFEN SODIUM 1 Oral 180 MG U 0
106066262 10606626 11 C PANTOSIN PANTETHINE 1 Oral 3000 MG U 0
106066262 10606626 12 C MAGNESIUM OXIDE. MAGNESIUM OXIDE 1 Oral 1500 MG U 0
106066262 10606626 13 C PLETAAL CILOSTAZOL 1 Oral 200 MG U 0
106066262 10606626 14 C MYSLEE ZOLPIDEM TARTRATE 1 Oral 5 MG U 0
106066262 10606626 15 C DUROTEP FENTANYL 1 Transdermal 4.2 MG U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
106066262 10606626 1 Cancer pain
106066262 10606626 3 Analgesic therapy
106066262 10606626 6 Analgesic therapy
106066262 10606626 8 Prostate cancer

Outcome of event

Event ID CASEID OUTC COD
106066262 10606626 LT
106066262 10606626 DE

Reactions reported

Event ID CASEID DRUG REC ACT PT
106066262 10606626 Altered state of consciousness
106066262 10606626 Prostate cancer

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
106066262 10606626 1 20140728 20140731 0
106066262 10606626 2 20140731 20140801 0
106066262 10606626 3 20140509 20140729 0
106066262 10606626 4 20140730 20140730 0
106066262 10606626 5 20140801 20140802 0
106066262 10606626 6 20140616 20140729 0
106066262 10606626 7 20140731 20140731 0
106066262 10606626 8 20140527 20140801 0
106066262 10606626 9 20140622 20140801 0
106066262 10606626 10 20140319 20140801 0
106066262 10606626 11 20140531 20140801 0
106066262 10606626 12 20140531 20140801 0
106066262 10606626 13 20140704 20140730 0
106066262 10606626 14 20140713 20140801 0
106066262 10606626 15 20140731 20140731 0